Latest accounts payable for CMRAW: $1.1M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2023), CMRAW shows a accounts payable of $1.1M. That compares with $1.4M in the prior-year period — down 20.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CMRAW's accounts payable is now $1.1M (was $1.4M) — a 20.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Comera Life Sciences Holdings- Warrants (19/05/2027) is outperforming or lagging.
Tracking CMRAW's accounts payable over time shows whether Comera Life Sciences Holdings- Warrants (19/05/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.1M That compares with $1.4M in the prior-year period — down 20.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has Comera Life Sciences Holdings- Warrants (19/05/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.1M) with ownership activity and broader fundamentals.